EA200401123A1 - HALOGENACETAMIDE AND AZID-SUBSTITUTED COMPOUNDS AND METHODS OF THEIR APPLICATION - Google Patents
HALOGENACETAMIDE AND AZID-SUBSTITUTED COMPOUNDS AND METHODS OF THEIR APPLICATIONInfo
- Publication number
- EA200401123A1 EA200401123A1 EA200401123A EA200401123A EA200401123A1 EA 200401123 A1 EA200401123 A1 EA 200401123A1 EA 200401123 A EA200401123 A EA 200401123A EA 200401123 A EA200401123 A EA 200401123A EA 200401123 A1 EA200401123 A1 EA 200401123A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- conditions
- osteoporosis
- treatment
- androgen
- cancer
- Prior art date
Links
Abstract
Настоящее изобретение относится к новому классу агентов-мишеней андрогенового рецептора, (ARTA), которые содержат галогенацетамидную или азидную группу и являются алкилирующими агентами. Эти агенты составляют новый подкласс соединений, а именно селективных модуляторов андрогенового рецептора (SARM), которые отдельно или в композиции являются полезными для а) мужской контрацепции; б) лечения разнообразных гормонзависимых состояний, например состояний, связанных со снижением андрогена при старении мужчин (ADAM), таких как усталость, депрессия, уменьшенное либидо, половая дисфункция, эректильная дисфункция, гипогонадизм, остеопороз, потеря волос, анемия, тучность, саркопения, остеопения, остеопороз, мягкая гиперплазия простаты, изменения в настроении и восприятии и рак простаты; в) лечения состояний, связанных со снижением андрогена у женщин (ADIF), таких как половая дисфункция, уменьшенное половое либидо, гипогонадизм, саркопения, остеопения, остеопороз, изменения в восприятии и настроении, депрессия, анемия, потеря волос, тучность, эндометриоз, рак груди, рак матки и рак яичников; г) лечения и/или профилактики острых и/или хронических состояний атрофии мышц; д) профилактики и/или лечения состояний сухого глаза; е) оральной андрогензамещающей терапии; ж) уменьшения сферы действия, остановки или начала регресса рака простаты и/или з) вызывания апоптоза раковой клетки.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to a new class of target androgen receptor agents (ARTA), which contain a haloacetamide or azide group and are alkylating agents. These agents constitute a new subclass of compounds, namely, selective androgen receptor modulators (SARM), which, alone or in composition, are useful for a) male contraception; b) treatment of a variety of hormone-dependent conditions, such as conditions associated with androgen decline during male aging (ADAM), such as fatigue, depression, decreased libido, sexual dysfunction, erectile dysfunction, hypogonadism, osteoporosis, hair loss, anemia, obesity, sarcopenia, osteopenia , osteoporosis, mild prostatic hyperplasia, changes in mood and perception, and prostate cancer; c) treatment of conditions associated with androgen decline in women (ADIF), such as sexual dysfunction, decreased sexual libido, hypogonadism, sarcopenia, osteopenia, osteoporosis, changes in perception and mood, depression, anemia, hair loss, obesity, endometriosis, cancer breast, uterine and ovarian cancer; d) treating and / or preventing acute and / or chronic conditions of muscle atrophy; e) prevention and / or treatment of dry eye conditions; e) oral androgen replacement therapy; g) reduce the incidence, stop or start regression of prostate cancer and / or h) induce cancer cell apoptosis. The international application was published along with an international search report.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/084,678 US20020173495A1 (en) | 2000-08-24 | 2002-02-28 | Selective androgen receptor modulators and methods of use thereof |
PCT/US2003/003122 WO2003074471A1 (en) | 2002-02-28 | 2003-02-24 | Haloacetamide and azide substituted compounds and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200401123A1 true EA200401123A1 (en) | 2005-08-25 |
Family
ID=49447260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200401123A EA200401123A1 (en) | 2002-02-28 | 2003-02-24 | HALOGENACETAMIDE AND AZID-SUBSTITUTED COMPOUNDS AND METHODS OF THEIR APPLICATION |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR20040105208A (en) |
EA (1) | EA200401123A1 (en) |
TW (1) | TW200413282A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8853266B2 (en) * | 2001-12-06 | 2014-10-07 | University Of Tennessee Research Foundation | Selective androgen receptor modulators for treating diabetes |
-
2003
- 2003-02-24 EA EA200401123A patent/EA200401123A1/en unknown
- 2003-02-24 KR KR10-2004-7013474A patent/KR20040105208A/en not_active Application Discontinuation
- 2003-02-27 TW TW092104202A patent/TW200413282A/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW200413282A (en) | 2004-08-01 |
KR20040105208A (en) | 2004-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200401122A1 (en) | POLISHMISSIBLE SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF THEIR APPLICATION | |
EA200500022A1 (en) | N-MOSTIC SELECTIVE MODULATORS OF ANDROGENIC RECEPTORS AND METHODS OF THEIR APPLICATION | |
EA200602151A1 (en) | METABOLITES OF SELECTIVE MODULATORS OF ANDROGEN RECEPTORS AND METHODS OF THEIR APPLICATION | |
ATE533494T1 (en) | MULTIPLE SUBSTITUTED SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF | |
TW200503711A (en) | Methylene-bridged selective androgen receptor modulators and methods of use thereof | |
TW200502249A (en) | Heterocyclic selective androgen receptor modulators and methods of use thereof | |
TW200420571A (en) | Halogenated selective androgen receptor modulators and methods of use thereof | |
EA200401121A1 (en) | IRREVERSIBLE SELECTIVE MODULATORS OF THE ANDROGEN RECEPTOR AND METHODS OF THEIR APPLICATION | |
EA200501761A1 (en) | PROTECTIVE FORMS OF SELECTIVE MODULATORS OF ANDROGEN RECEPTORS AND METHODS OF THEIR APPLICATION | |
CY1123239T1 (en) | COMPOSITIONS AND METHODS FOR SUPPRESSING ENDOMETRIAL HYPERPLASIA | |
EA201990835A2 (en) | ANTIPROGESTIN DOSAGE MODES | |
TNSN07005A1 (en) | TETRAPEPTITIIC ANALOGS | |
EA200300283A1 (en) | SELECTIVE MODULATORS OF THE ANDROGEN RECEPTOR AND METHODS OF THEIR APPLICATION | |
WO2004064747A3 (en) | Treating androgen deficiency in female (adif)-associated conditions with sarms | |
EA201001785A1 (en) | MODULATORS OF SPHINGOZIN-1-PHOSPHATE RECEPTORS | |
EA201070725A1 (en) | BIS-Pyridylpyridones as antagonists of receptor 1 melaninconcentrating hormone | |
EA202191785A1 (en) | ANTIBODIES TO CTLA4 AND METHODS OF THEIR APPLICATION | |
WO2009134725A3 (en) | Monomethylamine progesteron antagonists such as cdb-4453 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc | |
EA200401123A1 (en) | HALOGENACETAMIDE AND AZID-SUBSTITUTED COMPOUNDS AND METHODS OF THEIR APPLICATION | |
EA202193334A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING FXR AGONIST AND FIBRATE FOR USE IN THE TREATMENT OF CHOLESTATIC LIVER DISEASE | |
RU2008101503A (en) | METHOD FOR PREPARING CONCRETE MIX | |
BR0308076A (en) | Irreversibly selective selective androgen receptors and their methods of use | |
PE20081313A1 (en) | PYRROLIDINONE ANILINES AS MODULATORS OF PROGESTERONE RECEPTORS | |
SV2005002128A (en) | "NEW DERIVATIVES OF INDAZOL AND INDOLONA AND ITS USE AS PHARMACEUTICAL PRODUCTS" REF. PC32256A | |
MX2018002510A (en) | A pharmaceutical combination for mood disorders. |